STL Index for: Yash Jani
Delgocitinib Cream for Chronic Hand Dermatitis: Efficacy, Safety and Clinical Application
Delgocitinib 2% cream is the first topical pan-JAK inhibitor approved for moderate-to-severe chronic hand dermatitis. This review covers its mechanism, phase 2 and DELTA 1–3 trial results, long-term safety without a boxed warning, and its role as a steroid-sparing option in clinical practice.
